OCCPR: A Leader in Cancer Proteomics and Proteogenomics

Welcome to the Office of Cancer Clinical Proteomics Research (OCCPR), your dedicated organization in integrating proteomics and proteogenomics into cancer research science to improve cancer diagnosis, treatments, and outcomes.
Stay connected with us as we work towards groundbreaking research in clinical cancer proteogenomics. Keep up to date by signing up for our email updates.
Explore OCCPR
Latest News and Announcements
Sign Up for Email Updates
To receive the latest proteomics news and announcements from the National Cancer Institute's Office of Cancer Clinical Proteomics Research, sign up to the mailing list.
To sign up for our email list:
- Visit the National Cancer Institute's subscription topic page.
- Enter your email address and select 'Next'.
- Scroll down and check the box for 'NCI Proteomics News and Announcements'.
- Submit your subscriber preferences and look out for the next email announcement.